T1	PROC 45 81	Estudio de seguimiento a largo plazo
T2	PROC 536 560	consentimiento informado
#1	AnnotatorNotes T2	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T3	PROC 98 114	ensayos clínicos
#2	AnnotatorNotes T3	C0008976; Clinical Trials; Research Activity
T4	DISO 118 142	atrofia muscular espinal
#3	AnnotatorNotes T4	C0026847; Spinal Muscular Atrophy; Disease or Syndrome
T5	DISO 185 209	Atrofia Muscular Espinal
#4	AnnotatorNotes T5	C0026847; Spinal Muscular Atrophy; Disease or Syndrome
T6	DISO 252 255	AME
#5	AnnotatorNotes T6	C0026847; Spinal Muscular Atrophy; Disease or Syndrome
T7	ANAT 314 330	neuronas motoras
#6	AnnotatorNotes T7	C0026609; Motor Neurons; Cell
T8	PROC 354 386	tratamiento de reemplazo del gen
T9	PROC 402 417	estudio clínico
#7	AnnotatorNotes T9	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T10	PROC 579 593	procedimientos
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T11	CHEM 155 163	AVXS-101
#9	AnnotatorNotes T11	C5140028; onasemnogene abeparvovec; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T12	PROC 759 784	seguimiento a largo plazo
#10	AnnotatorNotes T12	C1517942; Long-term Follow-up; Health Care Activity
T13	ANAT 126 134	muscular
#11	AnnotatorNotes T13	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T14	ANAT 135 142	espinal
#12	AnnotatorNotes T14	C0037949; Vertebral column; Body Part, Organ, or Organ Component
T15	ANAT 193 201	Muscular
#13	AnnotatorNotes T15	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T16	ANAT 202 209	Espinal
#14	AnnotatorNotes T16	C0037949; Vertebral column; Body Part, Organ, or Organ Component
T17	Date 13 17	2019
T18	Date 68 81	a largo plazo
T19	LIVB 85 94	pacientes
#15	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	LIVB 238 247	Pacientes
#16	AnnotatorNotes T20	C0030705; Patients; Patient or Disabled Group
T21	GENE 281 330	gen 2 de la supervivencia de las neuronas motoras
#17	AnnotatorNotes T21	C1420258; SMN2 (survival of motor neuron 2) gene; Gene or Genome
T22	GENE 383 386	gen
#18	AnnotatorNotes T22	C0017337; Genes; Gene or Genome
T23	LIVB 435 443	paciente
#19	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	LIVB 449 454	padre
#20	AnnotatorNotes T24	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T25	LIVB 455 460	madre
#21	AnnotatorNotes T25	C0026591; Mother (person); Family Group
T26	LIVB 662 670	paciente
#22	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 676 681	padre
#23	AnnotatorNotes T27	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T28	LIVB 682 687	madre
#24	AnnotatorNotes T28	C0026591; Mother (person); Family Group
T30	Neg_cue 711 713	no
T31	Date 771 784	a largo plazo
T32	LIVB 688 699	tutor legal
#25	AnnotatorNotes T32	C0023226; Legal Guardians; Population Group
T33	LIVB 461 472	tutor legal
#26	AnnotatorNotes T33	C0023226; Legal Guardians; Population Group
T34	CHEM 387 395	AVXS-101
#27	AnnotatorNotes T34	C5140028; onasemnogene abeparvovec; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T29	PROC 625 632	visitas
#28	AnnotatorNotes T29	C1512346; Patient Visit; Health Care Activity
A1	Assertion T12 Negated
#29	AnnotatorNotes T18	C0443252; Long-term; Temporal Concept
#30	AnnotatorNotes T31	C0443252; Long-term; Temporal Concept
#31	AnnotatorNotes T1	C1517942; Long-term Follow-up; Health Care Activity
T35	Observation 719 755	dispuesto a participar en el estudio
A2	Assertion T35 Negated
R1	Overlap Arg1:T1 Arg2:T18	
R2	Experiences Arg1:T19 Arg2:T4	
R3	Location_of Arg1:T13 Arg2:T4	
R4	Location_of Arg1:T14 Arg2:T4	
R5	Experiences Arg1:T19 Arg2:T11	
R6	Location_of Arg1:T15 Arg2:T5	
R7	Location_of Arg1:T16 Arg2:T5	
T36	Quantifier_or_Qualifier 261 276	1, 2 o 3 copias
R8	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T36	
R9	Experiences Arg1:T20 Arg2:T6	
R10	Experiences Arg1:T20 Arg2:T8	
R11	Used_for Arg1:T34 Arg2:T8	
T37	Observation 484 493	dispuesto
#32	AnnotatorNotes T37	C0600109; Willing; Finding
R12	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T37	
R13	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T37	
R14	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T37	
R15	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T37	
T38	Observation 500 632	capaz de cumplimentar el proceso de consentimiento informado y cumplir con los procedimientos del estudio y el calendario de visitas
R16	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T38	
R17	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T38	
R19	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T38	
R18	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T38	
R20	Negation Arg1:T30 Arg2:T35	
R21	Overlap Arg1:T12 Arg2:T31	
R22	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T35	
R23	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T35	
R24	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T35	
R25	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T35	
R26	Negation Arg1:T30 Arg2:T12	
R27	Overlap Arg1:T6 Arg2:T21	
#33	AnnotatorNotes T8	C1304648; Gene replacement therapy; Laboratory Procedure
A3	Experiencer T32 Other
A4	Experiencer T28 Family_member
A5	Experiencer T27 Family_member
A6	Experiencer T26 Patient
A7	Experiencer T33 Other
A8	Experiencer T25 Family_member
A9	Experiencer T24 Family_member
A10	Experiencer T23 Patient
A11	Experiencer T19 Patient
A12	Experiencer T20 Patient
